vs
CADIZ INC（CDZI）与Foghorn Therapeutics Inc.（FHTX）财务数据对比。点击上方公司名可切换其他公司
Foghorn Therapeutics Inc.的季度营收约是CADIZ INC的1.8倍（$9.2M vs $5.1M），Foghorn Therapeutics Inc.同比增速更快（223.8% vs 7.0%），过去两年CADIZ INC的营收复合增速更高（113.0% vs 35.3%）
Cadiz Inc是一家总部位于美国的自然资源与可持续发展企业，核心业务包括水资源管理、农业用地运营及可再生能源项目开发，主要在加利福尼亚州开展业务，为市政、农业及商业客户提供稳定的供水解决方案与土地管护服务。
Foghorn Therapeutics是一家临床阶段生物技术企业，专注于开发靶向染色质调控系统的创新疗法，用于治疗多种癌症及其他严重疾病，目前推进多款靶向候选药物管线，通过自主研发与战略合作服务全球患者群体。
CDZI vs FHTX — 直观对比
营收规模更大
FHTX
是对方的1.8倍
$5.1M
营收增速更快
FHTX
高出216.7%
7.0%
两年增速更快
CDZI
近两年复合增速
35.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $5.1M | $9.2M |
| 净利润 | — | $-21.7M |
| 毛利率 | 33.0% | — |
| 营业利润率 | -145.4% | -258.2% |
| 净利率 | — | -234.3% |
| 营收同比 | 7.0% | 223.8% |
| 净利润同比 | — | -11.1% |
| 每股收益（稀释后） | — | $-0.35 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CDZIFHTX
| Q4 25 | $5.1M | $9.2M | ||
| Q3 25 | $4.1M | $8.2M | ||
| Q2 25 | $4.1M | $7.6M | ||
| Q1 25 | $3.0M | $6.0M | ||
| Q4 24 | $4.8M | $2.9M | ||
| Q3 24 | $3.2M | $7.8M | ||
| Q2 24 | $513.0K | $6.9M | ||
| Q1 24 | $1.1M | $5.0M |
净利润CDZIFHTX
| Q4 25 | — | $-21.7M | ||
| Q3 25 | $-7.1M | $-15.8M | ||
| Q2 25 | $-7.7M | $-17.9M | ||
| Q1 25 | $-9.6M | $-18.8M | ||
| Q4 24 | — | $-19.5M | ||
| Q3 24 | $-6.8M | $-19.1M | ||
| Q2 24 | $-8.9M | $-23.0M | ||
| Q1 24 | $-6.8M | $-25.0M |
毛利率CDZIFHTX
| Q4 25 | 33.0% | — | ||
| Q3 25 | 27.3% | — | ||
| Q2 25 | 35.4% | — | ||
| Q1 25 | 29.7% | — | ||
| Q4 24 | 36.1% | — | ||
| Q3 24 | 25.3% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 10.4% | — |
营业利润率CDZIFHTX
| Q4 25 | -145.4% | -258.2% | ||
| Q3 25 | -118.0% | -226.9% | ||
| Q2 25 | -140.0% | -279.2% | ||
| Q1 25 | -255.0% | -385.0% | ||
| Q4 24 | -139.5% | -840.5% | ||
| Q3 24 | -147.9% | -305.5% | ||
| Q2 24 | -1354.6% | -386.6% | ||
| Q1 24 | -437.8% | -558.3% |
净利率CDZIFHTX
| Q4 25 | — | -234.3% | ||
| Q3 25 | -170.5% | -194.4% | ||
| Q2 25 | -187.3% | -237.3% | ||
| Q1 25 | -324.7% | -316.4% | ||
| Q4 24 | — | -682.9% | ||
| Q3 24 | -210.7% | -244.9% | ||
| Q2 24 | -1729.4% | -333.6% | ||
| Q1 24 | -611.1% | -495.4% |
每股收益（稀释后）CDZIFHTX
| Q4 25 | — | $-0.35 | ||
| Q3 25 | — | $-0.25 | ||
| Q2 25 | — | $-0.28 | ||
| Q1 25 | — | $-0.30 | ||
| Q4 24 | — | $-0.23 | ||
| Q3 24 | — | $-0.31 | ||
| Q2 24 | — | $-0.45 | ||
| Q1 24 | — | $-0.59 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $8.6M | $80.9M |
| 总债务越低越好 | $72.7M | — |
| 股东权益账面价值 | $23.3M | $-108.5M |
| 总资产 | $140.9M | $198.1M |
| 负债/权益比越低杠杆越低 | 3.13× | — |
8季度趋势，按日历期对齐
现金及短期投资CDZIFHTX
| Q4 25 | $8.6M | $80.9M | ||
| Q3 25 | $4.4M | $89.3M | ||
| Q2 25 | $13.2M | $72.6M | ||
| Q1 25 | $21.6M | $61.0M | ||
| Q4 24 | $17.3M | $55.5M | ||
| Q3 24 | $3.3M | $57.7M | ||
| Q2 24 | $10.1M | $138.9M | ||
| Q1 24 | $19.2M | $79.3M |
总债务CDZIFHTX
| Q4 25 | $72.7M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $56.7M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益CDZIFHTX
| Q4 25 | $23.3M | $-108.5M | ||
| Q3 25 | $27.7M | $-89.7M | ||
| Q2 25 | $35.6M | $-76.7M | ||
| Q1 25 | $44.0M | $-61.7M | ||
| Q4 24 | $34.0M | $-45.5M | ||
| Q3 24 | $20.7M | $-28.3M | ||
| Q2 24 | $27.6M | $-14.3M | ||
| Q1 24 | $36.6M | $-97.5M |
总资产CDZIFHTX
| Q4 25 | $140.9M | $198.1M | ||
| Q3 25 | $128.0M | $205.0M | ||
| Q2 25 | $136.4M | $226.2M | ||
| Q1 25 | $145.6M | $258.7M | ||
| Q4 24 | $134.5M | $284.0M | ||
| Q3 24 | $112.6M | $308.4M | ||
| Q2 24 | $118.1M | $328.6M | ||
| Q1 24 | $118.1M | $255.0M |
负债/权益比CDZIFHTX
| Q4 25 | 3.13× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.67× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-6.9M | $-22.3M |
| 自由现金流经营现金流 - 资本支出 | $-8.2M | — |
| 自由现金流率自由现金流/营收 | -162.2% | — |
| 资本支出强度资本支出/营收 | 26.1% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-26.5M | — |
8季度趋势，按日历期对齐
经营现金流CDZIFHTX
| Q4 25 | $-6.9M | $-22.3M | ||
| Q3 25 | $-7.0M | $-18.9M | ||
| Q2 25 | $-1.4M | $-21.0M | ||
| Q1 25 | $-3.6M | $-24.0M | ||
| Q4 24 | $-6.2M | $-24.5M | ||
| Q3 24 | $-5.4M | $-21.0M | ||
| Q2 24 | $-7.1M | $-25.5M | ||
| Q1 24 | $-2.9M | $-29.3M |
自由现金流CDZIFHTX
| Q4 25 | $-8.2M | — | ||
| Q3 25 | $-7.5M | — | ||
| Q2 25 | $-5.9M | $-21.0M | ||
| Q1 25 | $-4.9M | $-24.0M | ||
| Q4 24 | $-6.6M | $-25.0M | ||
| Q3 24 | $-5.4M | $-21.3M | ||
| Q2 24 | $-7.3M | $-25.6M | ||
| Q1 24 | $-3.1M | $-29.4M |
自由现金流率CDZIFHTX
| Q4 25 | -162.2% | — | ||
| Q3 25 | -179.8% | — | ||
| Q2 25 | -142.2% | -278.2% | ||
| Q1 25 | -167.0% | -403.2% | ||
| Q4 24 | -139.4% | -875.3% | ||
| Q3 24 | -168.8% | -273.0% | ||
| Q2 24 | -1431.6% | -371.0% | ||
| Q1 24 | -272.9% | -583.1% |
资本支出强度CDZIFHTX
| Q4 25 | 26.1% | 0.0% | ||
| Q3 25 | 10.8% | 0.0% | ||
| Q2 25 | 109.3% | 0.3% | ||
| Q1 25 | 43.6% | 0.5% | ||
| Q4 24 | 8.7% | 16.8% | ||
| Q3 24 | 1.7% | 4.0% | ||
| Q2 24 | 54.8% | 0.2% | ||
| Q1 24 | 16.6% | 2.0% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CDZI
| Water Treatment | $4.4M | 86% |
| Other | $724.0K | 14% |
FHTX
暂无分部数据
